All Pharma News
ROME Therapeutics Appoints Heike Keilhack, Ph.D., as Chief Scientific Officer

ROME Therapeutics Appoints Heike Keilhack, Ph.D., as Chief Scientific Officer
BUSINESSWIRE
04 Jan 2024
Share Share
Rome’s ‘dark genome’ drug reduces autoimmune markers in mice

Rome’s ‘dark genome’ drug reduces autoimmune markers in mice
Helen Floersh FIERCE BIOTECH
17 Nov 2023
Share Share
Rome advances dark genome drug after completing $72M Series B extension

Rome advances dark genome drug after completing $72M Series B extension
Ayisha Sharma ENDPTS
12 Sep 2023
Share Share
ROME Therapeutics Closes Oversubscribed $72 Million Series B Extension

ROME Therapeutics Closes Oversubscribed $72 Million Series B Extension
BUSINESSWIRE
12 Sep 2023
Share Share
Rome builds out investor syndicate with J&J, BMS

Rome builds out investor syndicate with J&J, BMS
Annalee Armstrong FIERCE BIOTECH
12 Sep 2023
Share Share
ROME Appoints Keith Wilcoxen, Ph.D., as Executive Vice President

ROME Appoints Keith Wilcoxen, Ph.D., as Executive Vice President
BUSINESSWIRE
09 Mar 2023
Share Share
ROME & Enara Bio to Host Inaugural Dark Genome Symposium Convening Industry

ROME & Enara Bio to Host Inaugural Dark Genome Symposium Convening Industry
BUSINESSWIRE
02 Nov 2022
Share Share
ROME Tx Appoints Industry Veteran Jeff Hatfield as Chair of Board of Directors

ROME Tx Appoints Industry Veteran Jeff Hatfield as Chair of Board of Directors
BUSINESSWIRE
18 Jul 2022
Share Share
ROME Therapeutics Shows Preclinical Data Demonstrating Inhibition of eRT

ROME Therapeutics Shows Preclinical Data Demonstrating Inhibition of eRT
BUSINESSWIRE
08 Nov 2021
Share Share
ROME Therapeutics Secures $77M in Series B Financing to Advance its Pipeline

ROME Therapeutics Secures $77M in Series B Financing to Advance its Pipeline
BUSINESSWIRE
14 Sep 2021
Share Share